
Purpose: To introduce the concept of screening for the control of sexually transmissible infections (STIs) in a review article and specifically, to describe: the use of screening tests (including their sensitivity, specificity, positive predictive value and negative predictive value); the World Health Organization guidelines on screening; and the factors that determine the effectiveness of screening for STIs, particularly in Australian Indigenous communities. Methods: Recent articles published up to February 2001 were included using a MEDLINE search on 'Sexually transmitted diseases' and 'Mass screening'. Results: Screening for STIs involves the application of diagnostic testing to people who are not known to have infection. It may take place in contexts ranging from clinical settings to community- based programs. The effectiveness of screening for STIs at a population level is determined by several factors, including the ability of the program to reach people at higher risk of STI, the proportion of those with infection who do not have symptoms sufficient to cause them to seek treatment, the mean duration of an infection in the community without screening, the frequency of screening, the methods for selecting individuals in the community to be screened, the sensitivity of the laboratory test, the effectiveness of the proposed treatment, and the extent of any adverse health or social consequences of screening. The relative contribution of each of these factors varies across communities. Conclusions: Screening can greatly reduce the prevalence of STIs in populations. Prior to implementation, careful consideration should be given to factors that influence the effectiveness of screening programs, to increase the likelihood that they will achieve their goals. (author abstract)
Aims: To provide a review and analysis of the non-Australian literature on screening and mass treatment for bacterial sexually transmissible infections (STIs) for health services to consider in developing local programs. Methods: Systematic search of the English- language literature since 1985 via MEDLINE, with a more limited search back to 1970 and, in addition, hand searching of references cited in articles reviewed. Results: Various studies showed the feasibility of a broad range of strategies. Cost benefit studies demonstrated the utility of antenatal syphilis screening at very low prevalences of disease and of chlamydia screening in women at prevalences of 2 to 14 per cent. Chlamydia screening programs in America and Sweden involving millions of people over several years were followed by large falls in rates of infection. A randomised controlled trial of screening for chlamydia was followed by a substantially lower incidence of pelvic inflammatory disease. Mass treatment programs were associated with reduced rates of infection in treated groups and their sexual partners who were not treated. Conclusions: Taken individually, the lack of control groups and the influence of simultaneous education and condom promotion in most studies make it impossible to directly ascribe the reduction in infection to screening. However, the body of evidence strongly suggests that, if appropriately conducted, screening programs can have a positive effect, particularly for chlamydia. The literature provides many examples to assist the development of locally appropriate strategies. (author abstract)
The National Public Health Partnership decided in June 2001 to abandon a wide ranging national sexual health framework and instead to give priority to the development of a national approach to the control of sexually transmitted infections. (non-author abstract)